Cell type specific applicability of 5-ethynyl-2′-deoxyuridine (EDU) for dynamic proliferation assessment in flow cytometry

Cytometry Part A

Volumn 75, Issue 6, 2009, Pages 535-546

  Diermeier Daucher, Simone ^a   Clarke, Scott T ^b   Hill, Dani ^b   Vollmann Zwerenz, Arabel ^a   Bradford, Jolene A ^b   Brockhoff, Gero ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Molecular Probes/Invitrogen   (United States)

Author keywords

BrdU; BT474; Cell cycle kinetics; Cell death; Cell proliferation; Click chemistry; EdU; EdU Hoechst quenching; Necrosis; SK BR 3; Thymidine analogue

Indexed keywords

BROXURIDINE; CYCLIN B1; DNA; EDOXUDINE; HISTONE H2AX; LIPOCORTIN 5; PROPIDIUM IODIDE;

ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL DEATH; CELL LABELING; CELL PROLIFERATION; CELL TYPE; CELL VIABILITY; CONTROLLED STUDY; DNA DAMAGE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

APOPTOSIS; BROMODEOXYURIDINE; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CYCLIN B; DEOXYURIDINE; DNA; FEMALE; FLOW CYTOMETRY; HISTONES; HUMANS; PHOSPHORYLATION;

EID: 66449128220     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.20712     Document Type: Article

References (35)

1. Brockhoff G. DNA and proliferation analysis in flow cytometry. In: Sack U, Támok A, Rothe G, editors. Cellular Diagnostics - Basic Principles, Methods and Clinical Applications of Flow Cytometry. Freiburg, Germany: Karber Publishing; 2008. pp 390-425. ISBN: 978-3-8055-8555-2.
2. Brockhoff G, Heckel B, Schmidt-Bruecken E, Plander M, Hofstaedter F, Vollmann A, Diermeier S. Differential impact of Cetuximab, Pertuzumab and Trastuzumab on BT474 and SK-BR-3 breast cancer cell proliferation. Cell Prolif 2007;40:488-507.
3. Diermeier S, Horvath G, Knuechel-Clarke R, Hofstaedter F, Szollosi J, Brockhoff G. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation. Exp Cell Res 2005;304:604-619. (Pubitemid 40321136)
4. Diermeier S, Schmidt-Bruecken E, Kubbies M, Kunz-Schughart LA, Brockhoff G. Exposure to continuous bromodeoxyuridine (BrdU) differentially affects cell cycle progression of human breast and bladder cancer cell lines. Cell Prolif 2004;37:195-206. (Pubitemid 38429330)
5. Ormerod MG, Kubbies M. Cell cycle analysis of asynchronous cell populations by flow cytometry using bromodeoxyuridine label and Hoechst-propidium iodide stain. Cytometry 1992;13:678-685.
6. Wilson GD. Analysis of DNA-measurement of cell kinetics by the bromodeoxyuridine/anti-bromodeoxyuridine method. In: Ormerod MG, editor. Flow Cytometry: A Practical Approach, 2 ed. Oxford, UK: Oxford University Press; 1994. Vol.8, pp 137-156. ISBN: 978-0-19-963824-6.
7. Dolbeare F, Selden JR. Immunochemical quantitation of bromodeoxyuridine: Application to cell-cycle kinetics. Methods Cell Biol 1994;41:297-316.
8. Takagi S, McFadden ML, Humphreys RE, Woda BA, Sairenji T. Detection of 5-bromo-2-deoxyuridine (BrdUrd) incorporation with monoclonal anti-BrdUrd antibody after deoxyribonuclease treatment. Cytometry 1993;14:640-648. (Pubitemid 23245268)
9. Salic A, Mitchison TJ. A chemical method for fast and sensitive detection of DNA synthesis in vivo. Proc Natl Acad Sci USA 2008;105:2415-2420.
10. Buck SB, Bradford J, Gee KR, Agnew BJ, Clarke ST, Salic A. Detection of S-phase cell cycle progression using 5-ethynyl-2′-deoxyuridine incorporation with click chemistry, an alternative to using 5-bromo-2′- deoxyuridine antibodies. Biotechniques 2008;44:927-929.
11. Kubbies M, Hoehn H, Schindler D, Chen YC, Rabinovitch PS. Cell cycle analysis via BrdU-Hoechst flow cytometry: Principles and applications. In: Yen A, editor. Flow Cytometry: Advanced Research and Clinical Applications, Vol.11. Boca Raton, Florida: CRC Press; 1989. pp 5-28.
12. Poot M, Hoehn H, Kubbies M, Grossmann A, Chen Y, Rabinovitch PS. Cell-cycle analysis using continuous bromodeoxyuridine labeling and Hoechst 33358-ethidium bromide bivariate flow cytometry. Methods Cell Biol 1994;41:327-340.
13. Goz B. The effects of incorporation of 5-halogenated deoxyuridines into the DNA of eukaryotic cells. Pharmacol Rev 1977;29:249-272. (Pubitemid 9092686)
14. Balzarini J, De Clercq E, Kiefer G, Keppeler K, Buchele A. Antitumor cell and antimetabolic effects of 5-ethyl-2′-deoxyuridine and 5′-substituted 5-ethyl-2′-deoxyuridine derivatives. Invest New Drugs 1984;2:35-47. (Pubitemid 14123857)
15. Meuth M, Green H. Induction of a deoxycytidineless state in cultured mammalian cells by bromodeoxyuridine. Cell 1974;2:109-112.
16. Rabinovitch PS. Regulation of human fibroblast growth rate by both noncycling cell fraction transition probability is shown by growth in 5-bromodeoxyuridine followed by Hoechst 33258 flow cytometry. Proc Natl Acad Sci USA 1983;80:2951-2955.
17. Feng L, Achanta G, Pelicano H, Zhang W, Plunkett W, Huang P. Role of p53 in cellular response to anticancer nucleoside analog-induced DNA damage. Int J Mol Med 2000;5:597-604.
18. Damaraju D, Damaraju VL, Brun M, Mowles D, Kuzma M, Berendt RC, Sawyer MB, Cass CE. Cytotoxic activities of nucleoside and nucleobase analog drugs in malignant mesothelioma: Characterization of a novel nucleobase transport activity. Biochem Pharmacol 2008;75:1901-1911.
19. Ho GH, Calvano JE, Bisogna M, Abouezzi Z, Borgen PI, Cordon-Cardo C, van Zee KJ. Genetic alterations of the p14ARF -hdm2-p53 regulatory pathway in breast carcinoma. Breast Cancer Res Treat 2001;65:225-232. (Pubitemid 32328543)
20. Fedier A, Fink D. Mutations in DNA mismatch repair genes: Implications for DNA damage signaling and drug sensitivity (review). Int J Oncol 2004;24:1039-1047.
21. Karran P. DNA double strand break repair in mammalian cells. Curr Opin Genet Dev 2000;10:144-150. (Pubitemid 30182246)
22. Huang X, King MA, Halicka HD, Traganos F, Okafuji M, Darzynkiewicz Z. Histone H2AX phosphorylation induced by selective photolysis of BrdU-labeled DNA with UV light: Relation to cell cycle phase. Cytometry A 2004;62:1-7. (Pubitemid 39473449)
23. Cappella P, Gasparri F, Pulici M, Moll J. A novel method based on click chemistry, which overcomes limitations of cell cycle analysis by classical determination of BrdU incorporation, allowing multiplex antibody staining. Cytometry A 2008;73:626-636.
24. Brockhoff G, Heiss P, Schlegel J, Hofstaedter F, Knuechel R. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells. Cytometry 2001;44:338-348.
25. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995;184:39-51.
26. Bjursell G, Reichard P. Effects of thymidine on deoxyribonucleoside triphosphate pools and deoxyribonucleic acid synthesis in Chinese hamster ovary cells. J Biol Chem 1973;248:3904-3909.
27. Cleaver JE. The relationship between the rate of DNA synthesis and its inhibition by ultraviolet light in mammalian cells. Radiat Res 1967;30:795-810.
28. Kaufman ER, Davidson RL. Biological and biochemical effects of bromodeoxyuridine and deoxycytidine on Syrian hamster melanoma cells. Somatic Cell Genet 1978;4:587-601. (Pubitemid 8396536)
29. Endl E, Steinbach P, Knuchel R, Hofstadter F. Analysis of cell cycle-related Ki-67 and p120 expression by flow cytometric BrdUrd-Hoechst/7AAD and immunolabeling technique. Cytometry 1997;29:233-241. (Pubitemid 27501794)
30. Clute P, Pines J. Temporal and spatial control of cyclin B1 destruction in metaphase. Nat Cell Biol 1999;1:82-87. (Pubitemid 129501948)
31. Soto D, Sukumar S. Improved detection of mutations in the p53 gene in human tumors as single-stranded conformation polymorphs and double-stranded heteroduplex DNA. PCR Methods Appl 1992;2:96-98.
32. Oh SJ, Jung JY, Shim SS, Im MY, Kim HD, Chung SY, Yoon JH. Identification of p53 gene mutations in breast cancers and their effects on transcriptional activation function. Mol Cells 2000;10:275-280.
33. Martin AC, Facchiano AM, Cuff AL, Hernandez-Boussard T, Olivier M, Hainaut P, Thornton JM. Integrating mutation data and structural analysis of the TP53 tumor-suppressor protein. Hum Mutat 2002;19:149-164. (Pubitemid 34121806)
34. Blandino G, Levine AJ, Oren M. Mutant p53 gain of function: Differential effects of different p53 mutants on resistance of cultured cells to chemotherapy. Oncogene 1999;18:477-485. (Pubitemid 29060623)
35. Tarnok A, Bocsi J, Brockhoff G. Cytomics-importance of multimodal analysis of cell function and proliferation in oncology. Cell Prolif 2006;39:495-505. (Pubitemid 44760201)